Abstract
We have modeled the within-patient evolutionary process during HIV infection. During the HIV infection several quasispecies of the virus arise. These quasispecies are able to use different coreceptors, in particular the CCR5 and CXCR4 (R5 and X4 phenotypes, respectively). The switch in coreceptor usage has been correlated with a faster progression of the disease to the AIDS phase. As several pharmaceutical companies are getting ready to start large phase III trials for their R5 blocking drugs, models are needed to predict the co-evolutionary and competitive dynamics of virus strains. Moreover, we have considered CTLs response and effect of TNF. We present a model of HIV early infection and CTLs response which describes the dynamics of R5 quasispecie and a model of HIV late infection, specifying the R5 to X4 switch and effect of immune response. We report the following findings: quasispecies dynamics after superinfection or coinfection have time scales of several months and become even slower in presence of the CTLs response. In addition, we illustrate dynamics of HIV quasispecies on HAART, Maraviroc and Zinc-finger nucleases(ZFN) therapies. Our model represents a general framework to study the mutation and distribution of HIV quasispecies during disease progression, and can be used to design vaccines and drug therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Nagashima, K.A., Thompson, D.A., Rosenfield, S.I., et al.: Human Immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion. J. Infect. Dis. 183, 1121–1125 (2001)
Karlsson, I., Antonsson, L., Shi, Y., Oberg, M., Karlsson, A., Albert, J., Olde, B., Owman, c., Jansson, B., Fenyo, E.M.: Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype. J. Virol. 78, 11807–11815 (2004)
Gorry, P.R., Churchill, M., Crowe, S.M., Cunningham, A.L., Gabuzda, D.: Pathogenesis of macrophage tropic HIV. Curr. HIV Res. 3, 53–60 (2005)
Koot, M., Keet, I.P., Vos, A.H., de Goede, R.E., Roos, M.T., Coutinho, R.A., Miedema, F., Schellekens, P.T., Tersmette, M.: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med. 118, 681–688 (1993)
Davenport, M., Zaunders, J., Hazenberg, M., Schuitemaker, H., Rij, R.: Cell turnover and cell tropism in HIV-1 infection. Trends Microbiol. 10, 275–278 (2002)
Gray, L., Sterjovski, J., Churchill, M., Ellery, P., Nasr, N., Lewin, S.R., Crowe, S.M., Wesselingh, S.L., Cunningham, A.L., Gorry, P.R.: Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome. Virology 337, 384–398 (2005)
Herbeuval, J.P., Hardy, A.W., Boasso, A., Anderson, S.A., Dolan, M.J., Dy, M., Shearer, G.M.: Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: Role of type I IFN-producing plasmacytoid dendritic cells. Proc. Nat. Acad. Sci. USA 102, 13974–13979 (2005)
Pavlakis, G.N., Valentin, A., Morrow, M., Yarchoan, R.: Differential effects of TNF on HIV-1 expression: R5 inhibition and implications for viral evolution. In: Int. Conf. AIDS 2004, July 11-16, 15:(abstract no. MoOrA1048) (2004)
Eigen, M., McCaskill, J., Schuster, P.: The Molecular Quasi-Species. Adv. Chem. Phys. 75, 149–263 (1989)
Sguanci, L., Bagnoli, F., Li, P.: Modeling viral coevolution: HIV multi-clonal persistence and competition dynamics. Physica A 366, 333–346 (2006)
Biebricher, C.K., Eigen, M.: The error threshold. Virus Res. 107, 117–127 (2005)
Neumann, A.U., Lam, N.P., Dahari, H., Gretch, D.R., Wiley, T.E., Layden, T.J., Perelson, A.S.: Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-alpha Therapy. Science 282, 103–107 (1998)
Eigen, M., Schuster, P.: The hypercycle. Naturwissenschaften 64, 541–565 (1977)
Carrington, M., OBrien, S.J.: The influence of HLA genotype on AIDS. Annu. Rev. Med. 54, 535–551 (2003)
Kalams, S.A., Goulder, P.J., Shea, A.K., Jones, N.G., Trocha, A.K., et al.: Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J. Virol. 73, 6721–6728 (1999)
Borrow, P., Lewicki, H., Wei, X., Horwitz, M.S., Peffer, N., et al.: Antiviral pressure exerted by HIV-1specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3, 205–211 (1997)
Phillips, R.E., Rowland-Jones, S., Nixon, D.F., Gotch, F.M., Edwards, J.P., et al.: Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453–459 (1991)
Jin, X., Bauer, D.E., Tuttleton, S.E., Lewin, S., Gettie, A., et al.: Dramatic rise in plasma viremia after CD8() T cell depletion in simian immunodeficiency virusinfected macaques. J. Exp. Med. 189, 991–998 (1999)
Althaus, C.L., Be Boer, R.J.: Dynamics of Immune escape during HIV/SIV Infection. PLOS Computational Biology 4(7), e1000103 (2008)
Ho, D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M., Markowitz, M.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123–126 (1995)
Chao, L., Davenport, M.P., Forrest, S., Perelson, A.S.: A stochastic model of cytotoxic T cell responses. J. Theor. Biol. 228, 227–240 (2004)
Celada, F., Seiden, P.E.: Affinity maturation and hypermutation in a simulation of the humoral immune response. Eur. J. Immunol. 26, 1350–1358 (1996)
De Boer, R.J., Perelson, A.S.: Towards a general function describing T-cell proliferation. J. Theor. Biol. 175, 567–576 (1995)
Wodarz, D., Nowak, M.A.: HIV dynamics and evolution. BioEssays 24, 1178–1187 (2002)
Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M.D., Ho, D.: HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time. Science 271, 1582–1586 (1996)
Wiegel, F.W., Perelson, A.S.: Some scaling principles for the immune system. Immunol. Cell. Biol. 82, 127–131 (2004)
Wei, X., Ghosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A., Deutsch, P., Lifson, J.D., Bonhoeffer, S., Nowak, M.A., Hahn, B.H., Saag, M.S., Shaw, G.M.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117–122 (1995)
Sguanci, L., Bagnoli, F., Li, P.: Modeling HIV quasispecies evolutionary dynamics. BMC Evolutionary Biology 7, S5 (2007)
Bruch, C.L., Chao, L.: Evolvability of an RNA virus determined by its mutational neighborhood. Nature 406, 625–628 (2000)
Riddell, S.R., Watanabe, K.S., Goodrich, J.M., Li, C.R., Agha, M.E., Greenberg, P.D.: Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science (Wash. DC) 257, 238–241 (1992)
Cannon, M.J., Openshaw, P.J., Askonas, B.A.: Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168, 1163–1168 (1988)
Kaslow, R., Carrington, M., Apple, R., Park, L., Munoz, A., et al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2, 405–411 (1996)
Schmitz, J., Kuroda, M., Santra, S., Sasseville, V., Simon, M., et al.: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857–860 (1999)
Asquith, B., Edwards, C.T.T., Lipsitch, M., McLean, A.R.: Inefficient Cytotoxic T LymphocyteMediated Killing of HIV-1 Infected Cells In Vivo. PLOS Biology 4(4), 90 (2006)
Gulick, R.M., Lalezari, J., James, G.J., et al.: Maraviroc for Previously Treated Patients with R5 HIV-1 Infection. The New England Journal of Medicine 359, 14 (2008)
Lieberman-Blum, S.S., Fung, H.B., Bandres, J.C.: Maraviroc: A CCR5-Receptor Antagonist for the Treatment of HIV-1 Infection. Clinical Therapeutics 30, 7 (2008)
Dybul, M., Fauci, A.S., Bartlett, J.G., Kaplan, J.E., Pau, A.K.: Panel on Clinical Practices for Treatment of HIV (September 2002). “Guidelines for using antiretroviral agents among HIV-infected adults and adolescents”. Ann. Intern. Med. 137(5 Pt 2), 381–433 (2002)
Rossi, J.J., June, C.H., Kohn, D.B.: Genetic therapies against HIV: approximate methods. Nature Biotechnology 25, 1444–1454 (2007)
Perez, E.E., Wang, J., Miller, J.C., Jouvenot, Y., Kim, K.A., Liu, O., et al.: Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nature Biotechnology 26, 808–816 (2008)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Sorathiya, A., Liò, P., Sguanci, L. (2009). Mathematical Model of HIV Superinfection and Comparative Drug Therapy. In: Andrews, P.S., et al. Artificial Immune Systems. ICARIS 2009. Lecture Notes in Computer Science, vol 5666. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03246-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-03246-2_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03245-5
Online ISBN: 978-3-642-03246-2
eBook Packages: Computer ScienceComputer Science (R0)